KOL | Arthi ReddyFrom the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University ... |
KOL Resume for Arthi Reddy
| Year | |
|---|---|
| 2015 | From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone Medical Center; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical |
| 2013 | Nyu School of Medicine |
Arthi Reddy: Influence Statistics
| Concept | World rank |
|---|---|
| medications belimumab | #13 |
| soluble lymphocyte stimulator | #23 |
| belimumab benlysta | #23 |
| soluble blymphocyte stimulator | #41 |
| benlysta | #41 |
| initiation belimumab | #42 |
| onset antibodies monoclonal | #96 |
| efficacy belimumab | #98 |
Open the FULL List in Excel | |
Prominent publications by Arthi Reddy
Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.
[ PUBLICATION ]
OBJECTIVE: To evaluate the use and efficacy of belimumab in academic practices. Belimumab is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been approved for the treatment of adults with systemic lupus erythematosus (SLE).
METHODS: Invitations to participate and complete a 1-page questionnaire for each patient prescribed belimumab were sent to 16 physicians experienced in SLE phase III clinical trials. The outcome was defined as the physician's ...
| Known for Lupus Erythematosus | Patients Sle | 6 Months | Onset Antibodies | Efficacy Belimumab |
Key People For Lupus Erythematosus
Arthi Reddy:Expert Impact
Concepts for whichArthi Reddyhas direct influence:Lupus erythematosus, Systemic lupus erythematosus, Efficacy belimumab, Patients sle, Belimumab benlysta, Belimumab sle, Systemic lupus, Onset antibodies.
Arthi Reddy:KOL impact
Concepts related to the work of other authors for whichfor which Arthi Reddy has influence:Systemic lupus erythematosus, Belimumab patients, Treatment sle, Lupus nephritis, Maintenance therapy, Biological therapies, Damage progression.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |